The COVID-19 Pandemic – Multimedia

Women are at a slightly higher risk of having a heavier period after COVID vaccination, a study finds.

Speaking at the Vaccine Research & Development 2022 online symposium, Nikolai Petrovsky, Professor of Medicine at FLinder's University, delivered his talk on the first Australian-developed vaccine in over 40 years.

Simulations show that the proteins on the influenza viral surface targeted by vaccines can tilt and wave in “breath-like” motions, which could be exploited to better defend against the flu.

In a normal immune response, entry of the SARS-CoV-2 virus into lung tissue induces controlled activation of the immune system.

In this infographic, we explore what is meant by disease modeling and highlight how advanced cell models are helping researchers to overcome some of the limitations associated with classical cell lines and animal models.

Oligonucleotide therapeutics are short DNA or RNA molecules that modulate the expression of target RNA for the treatment of diseases. The success of mRNA-based COVID-19 vaccines has brought renewed interest to other nucleic acid drugs, and the oligo therapeutics market is expected to grow by 25–30% in the next five years with over 1,000 oligonucleotide molecules currently in the pipeline.

Speaking at the Advances in Drug Discovery & Development 2022 online symposium, Sterghios Moschos delivered his talk on targeted RNA therapeutics in the lung.

Since the onset of the pandemic, massive global need for pipette tips has more than tripled. Sartorius could significantly increase output and ill help laboratories worldwide to maintain their operations.

In this Teach Me in 10, Lucy Lawrence and Amy Kauffman will cover what extracellular vesicles (EVs) are, the therapeutic promise they hold as well as guidance on how to culture and scale.

The Cancer Research Institute hosted a special event with mRNA vaccine pioneers and 2021 Coley Award Winners Katalin Karikó, Ugur Sahin, Özlem Türeci and Drew Weissman. In this interview, the honorees shared their thoughts on how mRNA vaccine technology will transform cancer treatment in the future.